Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 11/20 | 0.51 |
| ▸ | CYP11B2 | P19099 | 9/20 | 0.47 |
| ▸ | CYP11B1 | P15538 | 6/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL35210214 | 1.00 | KIF11 (0.51) | KIF11CYP11B2CYP11B1 | |
| SCHEMBL21116892 | 0.78 | KIF11 (0.76) | KIF11CYP11B2CYP11B1 | |
| SCHEMBL22043741 | 0.74 | KDM4E (0.44) | — | |
| SCHEMBL22043740 | 0.74 | MAPT (0.40) | — | |
| SCHEMBL22043754 | 0.74 | ALDH1A1 (0.43) | KIF11 | |
| SCHEMBL24334730 | 0.74 | KMO (0.43) | — | |
| SCHEMBL22044253 | 0.74 | KDM4E (0.49) | CYP11B2CYP11B1 | |
| SCHEMBL22043776 | 0.74 | MAPT (0.40) | KIF11 | |
| SCHEMBL22043752 | 0.70 | KDM4E (0.53) | — | |
| SCHEMBL24039051 | 0.70 | PIK3CD (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220119359-A1 | NOVEL TETRAZINE COMPOUNDS FOR IN VIVO IMAGING | Københavns Universitet (DK) | 2022-04-21 | — | — | US | disclosed |
| WO-2020108720-A1 | NOVEL TETRAZINE COMPOUNDS FOR IN VIVO IMAGING | Københavns Universitet (DK) | 2020-06-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220119359-A1 | NOVEL TETRAZINE COMPOUNDS FOR IN VIVO IMAGING | RTN3, RXFP3, TAAR5 | KIF11 885/4885CYP11B2 2337/4885CYP11B1 2669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.